# A Double-Blind Study of Buprenorphine Treatment of Acute Suicidality

> **NCT00863291** · PHASE3 · UNKNOWN · sponsor: **Abarbanel Mental Health Center** · enrollment: 40 (estimated)

## Conditions studied

- Depression
- Suicidal Ideation
- Suicidal Action

## Interventions

- **DRUG:** buprenorphine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00863291
- **Lead sponsor:** Abarbanel Mental Health Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-11
- **Primary completion:** —
- **Final completion:** 2008-11
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2009-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00863291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00863291, "A Double-Blind Study of Buprenorphine Treatment of Acute Suicidality". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00863291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*